M, L., TB, P., S, F., LD, Ø., CA, P., C, E., . . . L, L. (2022). Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer. Research and reports in urology, 14, 33. https://doi.org/10.2147/RRU.S346978
Chicago Style (17th ed.) CitationM, Lund, Pedersen TB, Feddersen S, Østergaard LD, Poulsen CA, Enggaard C, Poulsen MHA, and Lund L. "Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer." Research and Reports in Urology 14 (2022): 33. https://doi.org/10.2147/RRU.S346978.
MLA (9th ed.) CitationM, Lund, et al. "Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer." Research and Reports in Urology, vol. 14, 2022, p. 33, https://doi.org/10.2147/RRU.S346978.
Warning: These citations may not always be 100% accurate.